Upjohn’s $7.45 Billion Senior Notes Offering and Concurrent €3.6 Billion Senior Notes Offering

Cravath represented Mylan N.V. in connection with Upjohn Inc.’s $7.45 billion 144A/Reg. S senior notes offering and Upjohn Finance B.V.’s €3.6 billion Reg. S senior notes offering. Upjohn Finance B.V. is a subsidiary of Upjohn Inc. The Upjohn Business currently operates as a business unit of Pfizer Inc. and is a global leader in the commercialization and manufacturing of pharmaceutical products. The Upjohn Finance B.V. notes were listed on the Global Exchange Market of Euronext Dublin. Proceeds of both offerings will be used to finance the pending combination of the Upjohn Business and Mylan N.V. The offering transactions closed on June 22, 2020 and June 23, 2020, respectively.

The Cravath team included associates Ryan J. Patrone and Kathryn Kennedy Bleday on capital markets matters, and partner J. Leonard Teti II and associates Kiran Sheffrin, Andrew T. Davis, Rebecca L. Fine and Rory M. Minnis on tax matters. Alexandra J. Valicenti also worked on capital markets matters.